Overview

RICE Trial: Rifaximin In Chronic Hepatic Encephalopathy - A Randomized, Controlled Trial

Status:
Terminated
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the effectiveness of three different treatments for hepatic encephalopathy.
Phase:
Phase 3
Details
Lead Sponsor:
University of Miami
Collaborators:
Bausch Health Americas, Inc.
Valeant Pharmaceuticals International, Inc.
Treatments:
Lactulose
Rifamycins
Rifaximin